Aquintis Pharma Private Limited
About Aquintis Pharma Private Limited
Data last updated:
Aquintis Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 12 November 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2001PTC113119. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kanak Lata and Shekhar Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 17 And 55 Basement Block – A Gulab Bagh, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹55.89 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.22 Lakh (net margin 2.2%) and EBITDA of ₹2.17 Lakh (EBITDA margin 3.9%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aquintis Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 17 And 55 Basement Block – A Gulab Bagh, New Delhi, Delhi, India – 110059
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Aquintis Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aquintis Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Aquintis Pharma Private Limited, buy the company report.
Financials of Aquintis Pharma Private Limited
FY 2025 filings availableAquintis Pharma Private Limited reported revenue of ₹55.89 Lakh (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 4% fall in the latest year. EBITDA fell 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aquintis Pharma Private Limited, buy the company report.
Board of directors of Aquintis Pharma Private Limited
Aquintis Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kanak Lata | Director | 20 Sep 2017 | 9 Years 1 Months | Current |
| Shekhar Kumar Singh | Director | 30 Sep 2002 | 24 Years 1 Months | Current |
Peer comparison
Aquintis Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atlas Stationery India Private Limited | ₹55.93 Lakh (FY 2016) | -28.0% | Ernakulam, Kerala, India | |||
| Sumanjoosha Ventures Private Limited | ₹55.93 Lakh (FY 2025) | -29.0% | Kanchipuram, Tamil Nadu, India | |||
| Sagar Overseas Private Limited | ₹55.92 Lakh (FY 2024) | -1.0% | Chennai, Tamil Nadu, India | |||
| Additri Info Solutions Private Limited | ₹55.9 Lakh (FY 2018) | -32.0% | Lucknow, Uttar Pradesh, India | |||
| Pipad Agro Foods Private Limited | ₹55.9 Lakh (FY 2025) | 248323.0% | Pipar, Rajasthan, India | |||
| Aquintis Pharma Private Limitedthis company | ₹55.89 Lakh (FY 2025) | ₹1.22 Lakh | 2.2% | -4.0% | New Delhi, Delhi, India | |
| V.K.Supreme Consultants Private Limited | ₹55.89 Lakh (FY 2025) | -18.0% | Jaipur, Rajasthan, India | |||
| Innovategreen Technologies Private Limited | ₹55.87 Lakh (FY 2025) | 23.0% | Paldi Cross Road, Paldi, Gujarat, India | |||
| Rajali Global Ventures (OPC) Private Limited | ₹55.87 Lakh (FY 2025) | 86.0% | Coimbatore, Tamil Nadu, India | |||
| Westrose Pharma Private Limited | ₹55.85 Lakh (FY 2025) | 19.0% | Lucknow, Uttar Pradesh, India | |||
| Jalpaiguri Farmer Producer Company Limited | ₹55.85 Lakh (FY 2025) | 63.0% | Jalpaiguri, West Bengal, India |
To see the full peer comparison of Aquintis Pharma Private Limited, buy the company report.
Auditor
Aquintis Pharma Private Limited is audited by VIMAL TANEJA MALLICK & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIMAL TANEJA MALLICK & ASSOCIATES | FY 2017 | 009957N |
Shareholding
The shareholding of Aquintis Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aquintis Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aquintis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aquintis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aquintis Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Aquintis Pharma Private Limited, buy the company report.
Recent activity
Aquintis Pharma Private Limited has 4 board changes on record since 2002: 2 appointments and 2 cessations. The latest: Sanjay Singh ceased to be Director on 22 Sep 2018.
Frequently asked questions
Aquintis Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 12 November 2001 (25+ years old) and is registered under CIN U51397DL2001PTC113119.
Aquintis Pharma has 2 current directors:
- Kanak Lata - Director
- Shekhar Kumar Singh - Director
The latest financial statements of Aquintis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Aquintis Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Aquintis Pharma is U51397DL2001PTC113119. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aquintis Pharma was incorporated on 12 November 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aquintis Pharma by revenue are Atlas Stationery India Private Limited, Sumanjoosha Ventures Private Limited, Sagar Overseas Private Limited, Additri Info Solutions Private Limited, Pipad Agro Foods Private Limited and 5 more, all in the same principal business activity (retail trading).
Sanjay Singh ceased to be Director on 22 Sep 2018. Suman Kumar Singh ceased to be Director on 22 Sep 2018. Kanak Lata was appointed as Director on 20 Sep 2017. Aquintis Pharma has 4 board changes on record in total.
The registered office of Aquintis Pharma is at Plot No. 17 And 55 Basement Block – A Gulab Bagh, New Delhi, Delhi, India – 110059.
Aquintis Pharma operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Aquintis Pharma is compliant as of 10 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
